Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Intervalo de año de publicación
1.
Org Lett ; 3(21): 3317-9, 2001 Oct 18.
Artículo en Inglés | MEDLINE | ID: mdl-11594823

RESUMEN

[reaction: see text]. Chiral dirhodium(II) complexes, Rh2(O2CCF3)2(PC)2, [PCH = (p-CH3C6H4)3P, (m-CH3C6H4)3P], provide an excellent yield and a high enantiocontrol in the cyclopropanation of alpha-diazo ketones with gamma and delta double bonds. The ee values are significantly dependent on the solvent used; the best results are obtained using pentane.

2.
Inorg Chem ; 40(17): 4226-9, 2001 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-11487326

RESUMEN

Two new dirhodium(II) catalysts of general formula Rh(2)(N-O)(2)[(C(6)H(4))P(C(6)H(5))(2)](2) (N-O = C(4)H(4)NO(2)) are prepared, starting from Rh(2)(O(2)CCH(3))(2)(PC)(2)L(2) [PC = (C(6)H(4))P(C(6)H(5))(2) (head-to-tail arrangement); L = HO(2)CCH(3)]. The thermal reaction of Rh(2)(O(2)CCH(3))(2)(PC)(2).L(2) with the neutral succinimide stereoselectively gives one compound that according to the X-ray structure determination has the formula Rh(2)(C(4)H(4)NO(2))(2)[(C(6)H(4))P(C(6)H(5))(2)](2) (1). It corresponds to the polar isomer with two bridging imidate ligands in a head-to-head configuration. However, stepwise reaction of Rh(2)(O(2)CCH(3))(2)(PC)(2).L(2) with (CH(3))(3)SiCl and potassium succinimidate yields a mixture of 1 and one of the two possible isomers (structure B) with a head-to-tail configuration of the imidate ligands, Rh(2)(C(4)H(4)NO(2))(2)[(C(6)H(4))P(C(6)H(5))(2)](2) (2), also characterized by X-ray methods. In solution, compound 2 undergoes slow isomerization to 1; the rate of this process is enhanced by the presence of acetonitrile. Compounds 1 and 2 are obtained as pure enantiomers starting from (M)- and (P)-Rh(2)(O(2)CCH(3))(2)(PC)(2).L(2) rather than from the racemic mixture. Their enantioselectivities in cyclopropanation of 1-diazo-5-penten-2-one are similar to those reported for the dirhodium amidate catalysts.

3.
Rev Esp Anestesiol Reanim ; 47(8): 372-3, 2000 Oct.
Artículo en Español | MEDLINE | ID: mdl-11103121
5.
Inorg Chem ; 39(26): 5964-9, 2000 Dec 25.
Artículo en Inglés | MEDLINE | ID: mdl-11188521

RESUMEN

The reactivity of the tetranuclear metallated palladium compound (Pd[mu 2-(C6H4)PPh2]Br)4 (1) with different ligands has been investigated with the aim of evaluating the influence of the entering ligand on the nature of the reaction products. The results confirmed the ability of the ligand [(C6H4)PPh2]- to expand a bridging [mu 2-] or a chelating [eta 2-] coordination mode, depending on the auxiliary ligands present in the complex. Bulky phosphines stabilize mononuclear species of formula (Pd[eta 2-(C6H4)PPh2]Br[P]), with a four-atom metallocycle, while small phosphines give dinuclear compounds. The molecular structures of three different metalated palladium compounds have been determined by single-crystal X-ray crystallography; the tetranuclear (Pd[mu 2-(C6H4)PPh2]Cl)4 (2), the dinuclear(Pd[mu 2-(C6H4)PPh2]Br[PMe3])2 (3), and the mononuclear (Pd[eta 2-(C6H4)PPh2]Br[PCBr]), (PCBr = P(o-BrC6H4)Ph2) (9) were obtained, the first one by halogen exchange reaction and the others by frame degradation of 1.

6.
Acta Otorrinolaringol Esp ; 42(1): 13-9, 1991.
Artículo en Español | MEDLINE | ID: mdl-2036256

RESUMEN

We have studied a group of 8 patients that presented the Usher syndrome. We have analyzed their family genealogic tree, showing the hereditary pattern found. We have analyzed the cochlear and vestibular functions. The retinoic and ophthalmologic complications are evaluated. We have searched for possible olfactory and gustative neuroreceptors disease.


Asunto(s)
Oftalmopatías , Pérdida Auditiva Bilateral , Retinitis Pigmentosa , Adolescente , Adulto , Oftalmopatías/genética , Oftalmopatías/fisiopatología , Femenino , Pérdida Auditiva Bilateral/genética , Pérdida Auditiva Bilateral/fisiopatología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Linaje , Retinitis Pigmentosa/epidemiología , Retinitis Pigmentosa/genética , Retinitis Pigmentosa/fisiopatología , Síndrome
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA